Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 2
1989 1
1991 1
1994 1
1995 2
1997 2
1998 4
1999 1
2000 2
2002 3
2003 1
2004 1
2005 2
2006 5
2007 2
2008 1
2009 1
2010 1
2011 1
2013 1
2015 5
2017 4
2018 7
2019 7
2020 2
2021 7
2022 3
2023 2
2024 5
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C. Legendre CM, et al. Among authors: gaber o. N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981. N Engl J Med. 2013. PMID: 23738544 Free article. Clinical Trial.
Myeloid Sarcoma.
Magdy M, Abdel Karim N, Eldessouki I, Gaber O, Rahouma M, Ghareeb M. Magdy M, et al. Among authors: gaber o. Oncol Res Treat. 2019;42(4):224-229. doi: 10.1159/000497210. Epub 2019 Mar 6. Oncol Res Treat. 2019. PMID: 30840960 Review.
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.
Licht C, Greenbaum LA, Muus P, Babu S, Bedrosian CL, Cohen DJ, Delmas Y, Douglas K, Furman RR, Gaber OA, Goodship T, Herthelius M, Hourmant M, Legendre CM, Remuzzi G, Sheerin N, Trivelli A, Loirat C. Licht C, et al. Among authors: gaber oa. Kidney Int. 2015 May;87(5):1061-73. doi: 10.1038/ki.2014.423. Epub 2015 Feb 4. Kidney Int. 2015. PMID: 25651368 Free PMC article. Clinical Trial.
Summary of a consensus conference on heart-liver transplantation.
Kobashigawa J, VanWagner LB, Hall S, Emamaullee J, Entwistle JW, Ganger D, Gebel H, Jeevanandam V, Kaldas F, Kilic A, Kittleson M, Kushwaha S, Kwong A, Lui GK, Motayagheni N, Patel J, Patel N, Pereira N, Potter L, Sani M, Schiano TD, Shingina A; Consensus Conference participants. Kobashigawa J, et al. Am J Transplant. 2024 Mar;24(3):380-390. doi: 10.1016/j.ajt.2023.12.002. Epub 2023 Dec 9. Am J Transplant. 2024. PMID: 38072122 Free article.
Unexplained fever after pancreas transplantation.
Klasek R, Kuten SA, Patel SJ, Graviss EA, Nguyen DT, Hobeika MJ, Gaber OA, Podder H, Knight RJ. Klasek R, et al. Among authors: gaber oa. Clin Transplant. 2018 Sep;32(9):e13351. doi: 10.1111/ctr.13351. Epub 2018 Aug 11. Clin Transplant. 2018. PMID: 30019349
Cardiotoxicity with immune system targeting drugs: a meta-analysis of anti-PD/PD-L1 immunotherapy randomized clinical trials.
Rahouma M, Karim NA, Baudo M, Yahia M, Kamel M, Eldessouki I, Abouarab A, Saad I, Elmously A, Gray KD, Ghaly G, Gaber O, Kamal M, A Hassan A, Rahouma M, D'Ascenzo F, Morris J, Mohamed A, Girardi L, Gaudino M. Rahouma M, et al. Among authors: gaber o. Immunotherapy. 2019 Jun;11(8):725-735. doi: 10.2217/imt-2018-0118. Immunotherapy. 2019. PMID: 31088241 Free article.
Pulmonary sarcomatoid carcinoma: University of Cincinnati experience.
Karim NA, Schuster J, Eldessouki I, Gaber O, Namad T, Wang J, Xie C, Morris JC. Karim NA, et al. Among authors: gaber o. Oncotarget. 2017 Dec 18;9(3):4102-4108. doi: 10.18632/oncotarget.23468. eCollection 2018 Jan 9. Oncotarget. 2017. PMID: 29423107 Free PMC article.
74 results